Evaluating the Life Coping Program for children and adolescents
Feasibility of a Group-Based Intervention to Enhance Health-Related Quality of Life and Physical Activity in Children and Adolescents with Chronic Illness: a Study Protocol
NA · Haukeland University Hospital · NCT06709248
This study is testing a program to help kids and teens aged 8-16 with chronic illnesses learn coping skills and see if it improves their quality of life and physical activity.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 8 Years to 16 Years |
| Sex | All |
| Sponsor | Haukeland University Hospital (other) |
| Locations | 1 site (Bergen, Vestland) |
| Trial ID | NCT06709248 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the feasibility and acceptability of the Life Coping Program in children and adolescents aged 8-16 with various chronic illnesses. The study will recruit 60 participants along with a caregiver, tracking attendance and participation in the program. Health-related quality of life and physical activity levels will be measured before and after the intervention using standardized tools. The findings will inform the potential for a future randomized controlled trial based on the British Medical Research Council's framework for complex interventions.
Who should consider this trial
Good fit: Ideal candidates are children and adolescents aged 8-16 who have received treatment at Haukeland University Hospital for specific chronic conditions.
Not a fit: Patients with medical conditions that may hinder their participation or those unable to complete questionnaires in Norwegian may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance the quality of life and physical activity levels in children and adolescents with chronic health conditions.
How similar studies have performed: While this approach is based on established frameworks, the specific Life Coping Program's feasibility has not been previously tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have received treatment at Haukeland University Hospital * One or more of the following primary conditions: congenital heart defects, congenital oral clefts, premature birth before 32 weeks of gestation, completion of cancer treatment, chronic pain conditions, or significant burn injuries * Must be able to answer questionnaires in Norwegian Exclusion Criteria: * Medical condition that may hinder og alter participation * Treatment plan that may hinder or alter participation
Where this trial is running
Bergen, Vestland
- Haukeland university hospital - Department of Pediatrics — Bergen, Vestland, Norway (RECRUITING)
Study contacts
- Principal investigator: Mette Engan, MD PhD — Haukeland University Hospital
- Study coordinator: Lars Peder V Bovim, MSc
- Email: lars.peder.vatshelle.bovim@helse-bergen.no
- Phone: +4797682402
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Health Literacy, Health Related Quality of Life, Physical Activity, Pediatric ALL